Inceptionr LLC lessened its position in Colgate-Palmolive (NYSE:CL – Free Report) by 5.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,658 shares of the company’s stock after selling 753 shares during the quarter. Inceptionr LLC’s holdings in Colgate-Palmolive were worth $1,242,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Chicago Partners Investment Group LLC lifted its stake in shares of Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the period. Peak Financial Advisors LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $1,315,000. Carrera Capital Advisors lifted its stake in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares during the period. Fiduciary Alliance LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $4,066,000. Finally, Impact Partnership Wealth LLC purchased a new position in shares of Colgate-Palmolive in the 4th quarter valued at approximately $803,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on CL. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $101.61.
Colgate-Palmolive Stock Performance
CL stock opened at $93.30 on Friday. The company has a market cap of $75.72 billion, a P/E ratio of 26.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The stock’s fifty day moving average price is $88.74 and its 200-day moving average price is $95.26.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 EPS. On average, equities analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- How to Invest in Insurance Companies: A GuideĀ
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- When to Sell a Stock for Profit or Loss
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Super Micro Computer Is Now NASDAQ CompliantāBut Is It a Buy?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.